Radio and PodcastLive Radio & Podcasts

Search Radio and Podcast

Podcasts›OncLive® On Air›S18 Ep31: FDA Approval Insights: Integrating RP1 Plus Nivolumab Into Post–PD-1 Melanoma Practice: With Michael K. Wong, MD, PhD, FRPC

Science & Medicine

S18 Ep31: FDA Approval Insights: Integrating RP1 Plus Nivolumab Into Post–PD-1 Melanoma Practice: With Michael K. Wong, MD, PhD, FRPC

OncLive® On Air by Audioboom

Aug 28, 202622:12Science & Medicine

In today's episode, we spoke with Michael K. Wong, MD, PhD, FRPC. Dr Wong is a physician at Roswell Park Comprehensive Cancer Center in Buffalo, New York. In our exclusive interview, Dr Wong discussed the significance of...

Related Episodes

Continue listening to more episodes from OncLive® On Air.

S18 Ep33: Current Approaches and Future Directions for Early-Stage TNBC

Sep 4, 2026 - 28:35

Highlights from the PER® CME activity "Current Approaches and Future Directions for Early-Stage TNBC" — t...

S18 Ep32: Non–Small Cell Lung Cancer 2026 UPDATE

Aug 31, 2026 - 13:48

Two Onc Docs , hosted by Samantha A. Armstrong, MD, and Karine Tawagi, MD, is a podcast dedicated to prov...

S18 Ep31: Immunotherapy Decision-Making in CSCC Sits at the Intersection of Efficacy and Comorbidity: With Eric D. Whitman, MD; and Francis Paul Worden, MD

Aug 28, 2026 - 27:52

Eric D. Whitman, MD, and Francis Paul Worden, MD, discuss the integration of immunotherapy into the cutan...

S18 Ep30: FDA Approval Insights: Iberdomide-Based Therapy Adds Another Option for R/R Myeloma: With Sagar Lonial, MD, FACP, FASCO

Aug 27, 2026 - 8:01

In today’s episode, we welcomed Sagar Lonial, MD, FACP, FASCO, to discuss the significance of the August...

S18 Ep29: 𝘔𝘌𝘛 Alterations in NSCLC: Applying Diagnostic Advances and Targeted Therapies in a New Era of Treatment

Aug 24, 2026 - 29:14

Highlights from the PER® CME activity " MET Alterations in NSCLC: Applying Diagnostic Advances and Target...

S18 Ep28: Pancreatic Cancer Treatment Advances Call for a Renewed Focus on the Role of Liposomal Irinotecan: With Jennifer B. Valerin, MD, PhD

Aug 20, 2026 - 17:02

In today’s episode, we spoke with Jennifer B. Valerin, MD, PhD. Dr Valerin is an assistant professor in t...

S18 Ep27: Key Considerations for Health Equity and Patient-Centered Care in TNBC

Aug 17, 2026 - 25:59

Highlights from the PER® CME activity "Key Considerations for Health Equity and Patient-Centered Care in...

S18 Ep26: FDA Approval Insights: Gedatolisib Plus Fulvestrant ± Palbociclib for HR+, HER2-Negative, PIK3CA Wild-Type Advanced Breast Cancer: With Adam M. Brufsky, MD, PhD

Aug 14, 2026 - 10:47

In today’s episode, we spoke with Adam M. Brufsky, MD, PhD, about the FDA approval of gedatolisib (Revtor...